Conceivable Life Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Conceivable Life Sciences's estimated annual revenue is currently $10.8M per year.
- Conceivable Life Sciences's estimated revenue per employee is $155,000
- Conceivable Life Sciences's total funding is $38M.
Employee Data
- Conceivable Life Sciences has 70 Employees.
- Conceivable Life Sciences grew their employee count by 6% last year.
Conceivable Life Sciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & Co-CEO | Reveal Email/Phone |
2 | Founder & Co-CEO | Reveal Email/Phone |
3 | Founder & CEO | Reveal Email/Phone |
4 | Executive Assistant, Office the Co-founders | Reveal Email/Phone |
5 | Founder & CPO | Reveal Email/Phone |
6 | Chief Marketing Officer | Reveal Email/Phone |
7 | Chief Knowledge Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Chief Scientific Officer | Reveal Email/Phone |
10 | Chief Marketing Officer | Reveal Email/Phone |
Conceivable Life Sciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Conceivable Life Sciences?
Reimagining the IVF lab to increase by 10X the number of families who can be helped.
keywords:N/A$38M
Total Funding
70
Number of Employees
$10.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.5M | 70 | -21% | $29.4M |
#2 | $15.4M | 70 | 0% | N/A |
#3 | $9.5M | 70 | 15% | N/A |
#4 | $13.8M | 70 | 19% | $283M |
#5 | $15.3M | 70 | -3% | N/A |
